BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35323088)

  • 1. Identification of phosphodiesterase type-5 (PDE-5) inhibitors in herbal supplements using a tiered approach and associated consumer risk.
    Akuamoa F; Bovee TFH; van Dam R; Maro L; Wesseling S; Vervoort J; Rietjens IMCM; Hoogenboom RLAP
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2022 Jun; 39(6):1021-1032. PubMed ID: 35323088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [LC/Tribrid Orbitrap Analysis of Phosphodiesterase-5 Inhibitors and Their Analogs as Adulterants in Dietary Supplements].
    Sakamoto M; Minowa K; Kishimoto K; Nakajima J; Suzuki J; Moriyasu T; Fukaya H; Saito K
    Shokuhin Eiseigaku Zasshi; 2019; 60(4):96-107. PubMed ID: 31474657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hierarchical clustering of liquid chromatography-tandem mass spectrometry data for screening of phosphodiesterase type 5 inhibitors and their analogues in adulterated dietary supplements.
    Tachi M; Kobayashi S; Tomita K; Tanahashi T; Imanishi SY
    J Chromatogr A; 2022 Aug; 1678():463366. PubMed ID: 35914410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliable screening and classification of phosphodiesterase type 5 inhibitors in dietary supplements using gas chromatography / mass spectrometry combined with specific common ions.
    Lee W; Kim HJ; Lee ME; Kim BH; Park S; Lee JH; Lee YM; Oh HB; Hong J
    J Chromatogr A; 2020 Jul; 1623():461210. PubMed ID: 32505294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Erectile Dysfunction Drugs in Dietary Supplements by Liquid Chromatography Ion Trap Mass Spectrometry.
    Li C; Xu D; Moezzi B
    J Diet Suppl; 2021; 18(3):261-277. PubMed ID: 32351143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of 94 compounds related to sexual enhancement including sildenafil, tadalafil, vardenafil and their analogues in various formulations of dietary supplements and food samples using HPLC and LC-MS/MS.
    Lee JH; Min AY; Park OR; Han JH; Yang YJ; Kim H; Baek SY
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2021 May; 38(5):769-781. PubMed ID: 33818311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE-5 inhibitors in selected herbal supplements from the Ghanaian market for better erectile function as tested by a bioassay.
    Akuamoa F; Hoogenboom RLAP; Hamers A; Rietjens IMCM; Bovee TFH
    Toxicol In Vitro; 2021 Jun; 73():105130. PubMed ID: 33662516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel approach to simultaneous screening and confirmation of regulated pharmaceutical compounds in dietary supplements by LC/MS/MS with an information-dependent acquisition method.
    Lee HM; Lee BJ
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2011 Apr; 28(4):396-407. PubMed ID: 21416414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical methods for the detection and characterization of unapproved phosphodiesterase type 5 inhibitors (PDE-5i) used in adulteration of dietary supplements- a review.
    Kee CL; Ge X; Low MY; Gilard V; Malet-Martino M
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2023 Dec; 40(12):1495-1530. PubMed ID: 38011602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors.
    Campbell N; Clark JP; Stecher VJ; Thomas JW; Callanan AC; Donnelly BF; Goldstein I; Kaminetsky JC
    J Sex Med; 2013 Jul; 10(7):1842-9. PubMed ID: 23634714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and Determination of Synthetic PDE-5 Inhibitors in Adulterated Sexual Enhancement Supplements.
    Jairoun AA; Al-Hemyari SS; Shahwan M; Zyoud SH; Ibrahim B; Zyoud SH
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection, identification and quantification by 1H NMR of adulterants in 150 herbal dietary supplements marketed for improving sexual performance.
    Gilard V; Balayssac S; Tinaugus A; Martins N; Martino R; Malet-Martino M
    J Pharm Biomed Anal; 2015 Jan; 102():476-93. PubMed ID: 25459948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of Phosphodiesterase Type-5 Inhibitors (PDE-5) in Dietary Supplements.
    Gheorghiu ORC; Ciobanu AM; Guțu CM; Chițescu CL; Costea GV; Anghel DM; Vlasceanu AM; Baconi DL
    Molecules; 2023 May; 28(10):. PubMed ID: 37241857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of 94 PDE-5is and Their Analogs Including N-Desmethylthiosildenafil in Various Formulations of Dietary Supplements and Food Samples Using HPLC and LC-Q-TOF/MS.
    Lee JH; Park OR; Yang YJ; Han JH; Jung EJ; Kim NS; Baek SY
    J Chromatogr Sci; 2022 Dec; 60(10):953-962. PubMed ID: 35535451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of a tadalafil analogue as an adulterant in a dietary supplement for erectile dysfunction.
    Ulloa J; Sambrotta L; Redko F; Mazza ON; Garrido G; Becher EF; Muschietti L
    J Sex Med; 2015 Jan; 12(1):152-7. PubMed ID: 25402198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC-ESI-MS and LC-UV.
    Gratz SR; Flurer CL; Wolnik KA
    J Pharm Biomed Anal; 2004 Nov; 36(3):525-33. PubMed ID: 15522526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for multiple phosphodiesterase type 5 inhibitor drugs in dietary supplement materials by flow injection mass spectrometry and their quantification by liquid chromatography tandem mass spectrometry.
    Song F; El-Demerdash A; Lee SJ
    J Pharm Biomed Anal; 2012 Nov; 70():40-6. PubMed ID: 22695818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-ESI-MS/MS analysis of phosphodiesterase-5 inhibitors and their analogues in foods and dietary supplements in Korea.
    Jeong JH; Lee JH; Kim HJ; Park HJ; Hwang IS; Han KM; Yoon CY; Cho S; Kim WS
    Food Addit Contam Part B Surveill; 2016; 9(1):1-8. PubMed ID: 25263347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements.
    Kee CL; Ge X; Gilard V; Malet-Martino M; Low MY
    J Pharm Biomed Anal; 2018 Jan; 147():250-277. PubMed ID: 28903860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.